Papers: 10.18632/oncotarget.17869

https://doi.org/10.18632/oncotarget.17869

Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer

Cited by: 23
Author(s): Changwen Ning, Min Liang, Shuang Liu, Guan Wang, Holly Edwards, Yang Xia, Lisa Polin, Gregory Dyson, Jeffrey W. Taub, Ramzi M. Mohammad, Asfar S. Azmi, Lijing Zhao, Yubin Ge
Published: over 9 years ago

Software Mentions 1